Manchester Molecular Pathology Innovation Centre Annual Symposium
Time: 12:30 (with lunch) - 17:00 (with networking wine reception)
Venue: CityLabs, Nelson Street, M13 9NQ
Sorry, this event has now ended.
Manchester Molecular Pathology Innovation Centre (MMPathIC) is one of six molecular pathology nodes funded by MRC and EPSRC to facilitate the translation of stratified medicine discovery to biomarker-based tests in the clinic for patient benefit.
The MMPathIC Annual Symposium 2017 will provide an update on current activities, future strategy, and the opportunities available to researchers, clinicians and industry.
There will be the opportunity to find out how you might benefit from the flexible funding and industry ecosystem which has been generated through the MMPathIC infrastructure.
Confirmed speakers include:
- Arjun Sikand, Commercial Director, Health Innovation Manchester
- John Todd, Chief Scientific Officer, Singulex (MMPathIC) strategic industry partner)
- Simon Turner, Kurma Partners (French Venture Capitalist company and MMPathIC partner)
- Bobby Graham, Deputy Director, Stoller Biomaker Discovery Centre
In addition, Central Manchester University Hospital Foundation Trust (CMFT) Research and Innovation Director, Professor Neil Hanley will open the proceedings, and MMPathIC Director, Professor Tony Freemont will provide an update on successes and future ambitions.